A citation-based method for searching scientific literature

C David Mazer, Gregory M T Hare, Philip W Connelly, Richard E Gilbert, Nadine Shehata, Adrian Quan, Hwee Teoh, Lawrence A Leiter, Bernard Zinman, Peter Jüni, Fei Zuo, Nikhil Mistry, Kevin E Thorpe, Ronald M Goldenberg, Andrew T Yan, Kim A Connelly, Subodh Verma. Circulation 2020
Times Cited: 71



Nikole J Byrne, Nirmal Parajuli, Jody L Levasseur, Jamie Boisvenue, Donna L Beker, Grant Masson, Paul W M Fedak, Subodh Verma, Jason R B Dyck. JACC Basic Transl Sci 2017
Times Cited: 74




List of shared articles



Times cited

Sodium-glucose cotransporter 2 inhibitors at the intersection of cardiovascular, renal and metabolic care: an integrated and multidisciplinary approach to patient-centered care.
Subodh Verma, Eric Klug, Viacheslav Y Mareev, Zhanna D Kobalava, Kim A Connelly, Mustafa Arici, Otávio Berwanger, Anwar Santoso, Roopa Mehta, Gus Meglis,[...]. Curr Opin Cardiol 2020
0

Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis.
Vinay Garg, Subodh Verma, Kim A Connelly, Andrew T Yan, Aditya Sikand, Ankit Garg, Paul Dorian, Fei Zuo, Lawrence A Leiter, Bernard Zinman,[...]. Metabol Open 2020
5

Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function.
Volker Vallon, Subodh Verma. Annu Rev Physiol 2021
7



Empagliflozin Disrupts a Tnfrsf12a-Mediated Feed Forward Loop That Promotes Left Ventricular Hypertrophy.
Veera Ganesh Yerra, Sri Nagarjun Batchu, Golam Kabir, Suzanne L Advani, Youan Liu, Ferhan S Siddiqi, Kim A Connelly, Andrew Advani. Cardiovasc Drugs Ther 2021
0


Direct Cardiac Actions of the Sodium Glucose Co-Transporter 2 Inhibitor Empagliflozin Improve Myocardial Oxidative Phosphorylation and Attenuate Pressure-Overload Heart Failure.
Xuan Li, Qingguo Lu, Yunguang Qiu, Jussara M do Carmo, Zhen Wang, Alexandre A da Silva, Alan Mouton, Ana C M Omoto, Michael E Hall, Ji Li,[...]. J Am Heart Assoc 2021
2